Prostate cancer is prevalent with significant morbidity in the United States. Aspirin previously
has been found to be associated with reduced carcinogenesis of prostate cells. However, it …

Experimental studies have shown inhibitory effects of nonsteroidal anti-inflammatory drugs
on prostate cancer cell proliferation and reduction of prostate cancer metastasis, suggesting …

It has been hypothesized that aspirin and other nonsteroidal anti-inflammatory drugs can
decrease the risk of developing prostate and other cancers, although observational studies …

Experimental studies suggest a role for aspirin in the chemoprevention of prostate cancer
and epidemiological evidence supports a modest inverse association between regular …

Objective: To examine the relationship between daily aspirin use and risk of prostate cancer
in a large, racially diverse cohort of men followed for up to 32 years. Methods: The study …

Background Regular aspirin use probably protects against some malignancies including
prostate cancer (PC), but its impact on lethal PC is particularly unclear. Objective To …

Two studies at September's American Association for Cancer Research meeting build on
evidence suggesting that nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the risk of …

The cyclooxygenase 2 (COX-2) enzyme overexpression in prostate cancer has led to the
hypothesis that COX-2 inhibition may reduce prostate cancer growth. Some previous studies …

Purpose: A recent meta-analysis showed that aspirin was associated with reduced prostate
cancer risk. As anti-inflammatory medications lower PSA levels, whether these findings …

Epidemiological studies have suggested that aspirin may have a protective effect against
prostate cancer, but the evidence is still limited and inconsistent. The role of aspirin in …